Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

DCB Funding Opportunities

Funding Opportunity Announcements (FOA)

Title Announcement Number Opening Date Expiration Date Activity Code
HIV/AIDS and the Tumor Niche (U54 Clinical Trial Not Allowed) RFA-CA-20-016 3/15/2020 4/16/2020 U54
Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers NOT-CA-20-022 5/7/2020 1/8/2023 N/A
Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed) RFA-CA-20-032 2/19/2020 3/20/2020 R01
Co-infection and Cancer (R21 Clinical Trial Not Allowed) PAR-20-061 2/17/2020 1/8/2023 R21
Co-infection and Cancer (R01 Clinical Trial Not Allowed)  PAR-20-062 2/6/2020 1/8/2023 R01
Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01 Clinical Trial Not Allowed) PAR-19-361 10/12/2019 3/12/2022 U01
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) PAR-19-353 9/21/2019 5/28/2022 R01
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) PAR-19-354 9/21/2019 5/28/2022 R21
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) PAR-19-287 05/22/2019 11/16/2021 U01
Microbial-based Cancer Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-19-193 05/05/2019 05/08/2022 R01
Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) PAR-19-194 05/16/2019 05/08/2022 R21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) PAR-19-199 05/10/2019 11/09/2021 R21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) PAR-19-198 05/10/2019 11/09/2021 R01
Biology of Bladder Cancer (R01 Clinical Trial Optional) PAR-19-183 05/05/2019 05/08/2022 R01
Biology of Bladder Cancer (R21 Clinical Trial Optional) PAR-19-184 05/16/2019 05/08/2022 R21
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) RFA-CA-19-032 07/01/2019 08/04/2020 R01
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) PAR-19-101 12/30/2018 07/31/2020 U01
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-19-113 01/05/2019 01/08/2022 R01
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) PAR-18-830 10/07/2018 06/04/2021 R01
Synthetic Biology for Engineering Applications (R01 - Clinical Trial Optional) PAR-18-434 01/05/2018 09/08/2020 R01
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) PAR-18-846 09/24/2018 06/26/2021 R21
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) PAR-18-845 09/24/2018 06/16/2021 R01
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) PA-18-876 09/05/2018 09/08/2021 R01
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) PA-18-902 09/05/2018 09/08/2021 R01
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional) PA-18-738 05/05/2018 05/08/2021 R01
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional) PA-18-739 05/16/2018 05/08/2021 R21
Biology of Lung, and Head and Neck Preneoplasias (R21) PA-17-460 01/16/2018 01/08/2021 R21
Biology of Lung, and Head and Neck Preneoplasias (R01) PA-17-459 01/05/2018 01/08/2021 R01
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21) PA-17-449 09/16/2017 09/08/2020 R21
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) PA-17-440 09/05/2017 09/08/2020 R01
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) PAR-17-244 05/05/2017 05/08/2020 R01
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) PAR-17-245 05/05/2017 05/08/2020 R01
Mechanisms of Alcohol-associated Cancers (R21) PA-17-219 5/16/2017 09/08/2020 R21
Mechanisms of Alcohol-associated Cancers (R01) PA-17-220 05/05/2017 09/08/2020 R01